位置:首页 > 蛋白库 > NUP50_MOUSE
NUP50_MOUSE
ID   NUP50_MOUSE             Reviewed;         466 AA.
AC   Q9JIH2; Q3TG43; Q3TN17; Q6P1F4; Q6PAL4; Q8C2Y6; Q9CU02; Q9JK85;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 3.
DT   03-AUG-2022, entry version 163.
DE   RecName: Full=Nuclear pore complex protein Nup50;
DE   AltName: Full=50 kDa nucleoporin;
DE   AltName: Full=Nuclear pore-associated protein 60 kDa-like;
DE   AltName: Full=Nucleoporin Nup50;
GN   Name=Nup50; Synonyms=Npap60;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND DISRUPTION PHENOTYPE.
RC   TISSUE=Embryo;
RX   PubMed=10891500; DOI=10.1128/mcb.20.15.5631-5642.2000;
RA   Smitherman M., Lee K., Swanger J., Kapur R., Clurman B.E.;
RT   "Characterization and targeted disruption of murine nup50, a p27(Kip1)-
RT   interacting component of the nuclear pore complex.";
RL   Mol. Cell. Biol. 20:5631-5642(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   STRAIN=BALB/cJ;
RX   PubMed=10811608; DOI=10.1093/emboj/19.10.2168;
RA   Mueller D., Thieke K., Buergin A., Dickmanns A., Eilers M.;
RT   "Cyclin E-mediated elimination of p27 requires its interaction with the
RT   nuclear pore-associated protein mNPAP60.";
RL   EMBO J. 19:2168-2180(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J;
RC   TISSUE=Amnion, Bone marrow, Ovary, Pituitary, Testis, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-234, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Kidney, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-8; LYS-126 AND LYS-448, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1-46 IN COMPLEX WITH KPNA2, AND
RP   FUNCTION.
RX   PubMed=16222336; DOI=10.1038/sj.emboj.7600843;
RA   Matsuura Y., Stewart M.;
RT   "Nup50/Npap60 function in nuclear protein import complex disassembly and
RT   importin recycling.";
RL   EMBO J. 24:3681-3689(2005).
CC   -!- FUNCTION: Component of the nuclear pore complex that has a direct role
CC       in nuclear protein import (PubMed:10811608). Actively displaces NLSs
CC       from importin-alpha, and facilitates disassembly of the importin-
CC       alpha:beta-cargo complex and importin recycling (PubMed:16222336).
CC       Interacts with regulatory proteins of cell cycle progression including
CC       CDKN1B (PubMed:10891500, PubMed:10811608). This interaction is required
CC       for correct intracellular transport and degradation of CDKN1B
CC       (PubMed:10811608). {ECO:0000269|PubMed:10811608,
CC       ECO:0000269|PubMed:10891500, ECO:0000269|PubMed:16222336}.
CC   -!- SUBUNIT: Does not interact with TPR (By similarity). Interacts with
CC       Importin alpha-2, Importin beta, Importin beta-2, NUP153, Ran binding
CC       protein 7, CDKN1B and itself. {ECO:0000250,
CC       ECO:0000269|PubMed:16222336}.
CC   -!- SUBCELLULAR LOCATION: Nucleus, nuclear pore complex. Nucleus membrane
CC       {ECO:0000250|UniProtKB:O08587}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:O08587}; Nucleoplasmic side
CC       {ECO:0000250|UniProtKB:O08587}. Note=Localizes to the nucleoplasmic
CC       fibrils of the nuclear pore complex. Dissociates from the NPC structure
CC       early during prophase of mitosis. Associates with the newly formed
CC       nuclear membrane during telophase. In the testis, the localization
CC       changes during germ cell differentiation from the nuclear surface in
CC       spermatocytes to the whole nucleus (interior) in spermatids and back to
CC       the nuclear surface in spermatozoa. {ECO:0000250|UniProtKB:O08587,
CC       ECO:0000250|UniProtKB:Q9UKX7}.
CC   -!- TISSUE SPECIFICITY: Widely expressed at low levels. Highest in the
CC       developing neural tube and adult testes.
CC   -!- DOMAIN: Contains FG repeats. FG repeats are interaction sites for
CC       karyopherins (importins, exportins) and form probably an affinity
CC       gradient, guiding the transport proteins unidirectionally with their
CC       cargo through the NPC. FG repeat regions are highly flexible and lack
CC       ordered secondary structure. The overall conservation of FG repeats
CC       regarding exact sequence, spacing, and repeat unit length is limited.
CC       {ECO:0000305}.
CC   -!- DISRUPTION PHENOTYPE: NUP50 targeted disruption results in a complex
CC       phenotype characterized by neural tube defects, exencephaly,
CC       intrauterine growth retardation, and late embryonic lethality.
CC       {ECO:0000269|PubMed:10891500}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF229256; AAF34721.1; -; mRNA.
DR   EMBL; AF251799; AAF70057.1; -; mRNA.
DR   EMBL; AK018983; BAB31500.1; -; mRNA.
DR   EMBL; AK087706; BAC39975.1; -; mRNA.
DR   EMBL; AK133371; BAE21620.1; -; mRNA.
DR   EMBL; AK133562; BAE21727.1; -; mRNA.
DR   EMBL; AK141750; BAE24822.1; -; mRNA.
DR   EMBL; AK151947; BAE30821.1; -; mRNA.
DR   EMBL; AK152309; BAE31115.1; -; mRNA.
DR   EMBL; AK161713; BAE36546.1; -; mRNA.
DR   EMBL; AK165581; BAE38272.1; -; mRNA.
DR   EMBL; AK168888; BAE40705.1; -; mRNA.
DR   EMBL; CH466550; EDL04446.1; -; Genomic_DNA.
DR   EMBL; BC059239; AAH59239.1; -; mRNA.
DR   EMBL; BC060234; AAH60234.1; -; mRNA.
DR   EMBL; BC065102; AAH65102.1; -; mRNA.
DR   CCDS; CCDS27714.1; -.
DR   RefSeq; NP_057923.2; NM_016714.2.
DR   PDB; 2C1M; X-ray; 2.20 A; B=1-46.
DR   PDBsum; 2C1M; -.
DR   AlphaFoldDB; Q9JIH2; -.
DR   SMR; Q9JIH2; -.
DR   BioGRID; 201817; 6.
DR   ComplexPortal; CPX-4474; Nuclear pore complex.
DR   DIP; DIP-46130N; -.
DR   IntAct; Q9JIH2; 2.
DR   MINT; Q9JIH2; -.
DR   STRING; 10090.ENSMUSP00000131457; -.
DR   iPTMnet; Q9JIH2; -.
DR   PhosphoSitePlus; Q9JIH2; -.
DR   SwissPalm; Q9JIH2; -.
DR   EPD; Q9JIH2; -.
DR   MaxQB; Q9JIH2; -.
DR   PaxDb; Q9JIH2; -.
DR   PeptideAtlas; Q9JIH2; -.
DR   PRIDE; Q9JIH2; -.
DR   ProteomicsDB; 287858; -.
DR   DNASU; 18141; -.
DR   Ensembl; ENSMUST00000165443; ENSMUSP00000131457; ENSMUSG00000016619.
DR   Ensembl; ENSMUST00000230411; ENSMUSP00000155656; ENSMUSG00000016619.
DR   GeneID; 18141; -.
DR   KEGG; mmu:18141; -.
DR   UCSC; uc007xcq.1; mouse.
DR   CTD; 10762; -.
DR   MGI; MGI:1351502; Nup50.
DR   VEuPathDB; HostDB:ENSMUSG00000016619; -.
DR   eggNOG; KOG2724; Eukaryota.
DR   GeneTree; ENSGT00440000035348; -.
DR   HOGENOM; CLU_032593_0_0_1; -.
DR   InParanoid; Q9JIH2; -.
DR   OMA; DTNPLCD; -.
DR   OrthoDB; 793797at2759; -.
DR   PhylomeDB; Q9JIH2; -.
DR   TreeFam; TF106504; -.
DR   Reactome; R-MMU-159227; Transport of the SLBP independent Mature mRNA.
DR   Reactome; R-MMU-159230; Transport of the SLBP Dependant Mature mRNA.
DR   Reactome; R-MMU-159231; Transport of Mature mRNA Derived from an Intronless Transcript.
DR   Reactome; R-MMU-159236; Transport of Mature mRNA derived from an Intron-Containing Transcript.
DR   Reactome; R-MMU-170822; Regulation of Glucokinase by Glucokinase Regulatory Protein.
DR   Reactome; R-MMU-191859; snRNP Assembly.
DR   Reactome; R-MMU-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-MMU-3232142; SUMOylation of ubiquitinylation proteins.
DR   Reactome; R-MMU-3301854; Nuclear Pore Complex (NPC) Disassembly.
DR   Reactome; R-MMU-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-MMU-4085377; SUMOylation of SUMOylation proteins.
DR   Reactome; R-MMU-4551638; SUMOylation of chromatin organization proteins.
DR   Reactome; R-MMU-4570464; SUMOylation of RNA binding proteins.
DR   Reactome; R-MMU-4615885; SUMOylation of DNA replication proteins.
DR   Reactome; R-MMU-5578749; Transcriptional regulation by small RNAs.
DR   BioGRID-ORCS; 18141; 12 hits in 72 CRISPR screens.
DR   ChiTaRS; Nup50; mouse.
DR   EvolutionaryTrace; Q9JIH2; -.
DR   PRO; PR:Q9JIH2; -.
DR   Proteomes; UP000000589; Chromosome 15.
DR   RNAct; Q9JIH2; protein.
DR   Bgee; ENSMUSG00000016619; Expressed in ileal epithelium and 260 other tissues.
DR   Genevisible; Q9JIH2; MM.
DR   GO; GO:0005635; C:nuclear envelope; ISO:MGI.
DR   GO; GO:0031965; C:nuclear membrane; ISS:UniProtKB.
DR   GO; GO:0005643; C:nuclear pore; IDA:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISO:MGI.
DR   GO; GO:0051028; P:mRNA transport; IEA:UniProtKB-KW.
DR   GO; GO:0001841; P:neural tube formation; IMP:MGI.
DR   GO; GO:0006913; P:nucleocytoplasmic transport; IC:ComplexPortal.
DR   GO; GO:0006606; P:protein import into nucleus; IBA:GO_Central.
DR   DisProt; DP01879; -.
DR   Gene3D; 2.30.29.30; -; 1.
DR   IDEAL; IID50016; -.
DR   InterPro; IPR015007; NUP2/50/61.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR000156; Ran_bind_dom.
DR   InterPro; IPR045255; RanBP1-like.
DR   PANTHER; PTHR23138; PTHR23138; 1.
DR   Pfam; PF08911; NUP50; 1.
DR   Pfam; PF00638; Ran_BP1; 1.
DR   SMART; SM00160; RanBD; 1.
DR   PROSITE; PS50196; RANBD1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Isopeptide bond; Membrane; mRNA transport;
KW   Nuclear pore complex; Nucleus; Phosphoprotein; Protein transport;
KW   Reference proteome; Repeat; Translocation; Transport; Ubl conjugation.
FT   CHAIN           1..466
FT                   /note="Nuclear pore complex protein Nup50"
FT                   /id="PRO_0000204869"
FT   REPEAT          76..77
FT                   /note="1"
FT   REPEAT          112..113
FT                   /note="2"
FT   REPEAT          225..226
FT                   /note="3"
FT   REPEAT          271..272
FT                   /note="4"
FT   REPEAT          301..302
FT                   /note="5"
FT   DOMAIN          333..466
FT                   /note="RanBD1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00164"
FT   REGION          1..22
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          76..302
FT                   /note="5 X 2 AA repeats of F-G"
FT   REGION          128..150
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          143..205
FT                   /note="Binding to CDKN1B"
FT   REGION          200..257
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          316..343
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        200..217
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        225..241
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        242..256
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         8
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         52
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UKX7"
FT   MOD_RES         82
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UKX7"
FT   MOD_RES         126
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         208
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UKX7"
FT   MOD_RES         234
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         246
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UKX7"
FT   MOD_RES         268
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UKX7"
FT   MOD_RES         294
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UKX7"
FT   MOD_RES         448
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   CROSSLNK        351
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UKX7"
FT   CONFLICT        127..135
FT                   /note="KISSPKCNN -> VSNPKTNGD (in Ref. 2; AAF70057)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        158
FT                   /note="Q -> H (in Ref. 3; BAE40705)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        314
FT                   /note="L -> P (in Ref. 1; AAF34721)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        321
FT                   /note="E -> D (in Ref. 3; AAH60234)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        324
FT                   /note="A -> P (in Ref. 1; AAF34721)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        439..441
FT                   /note="LPA -> IKV (in Ref. 3; BAB31500)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        451
FT                   /note="E -> K (in Ref. 3; BAB31500)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        462..464
FT                   /note="EKK -> QKT (in Ref. 3; BAB31500)"
FT                   /evidence="ECO:0000305"
FT   TURN            12..14
FT                   /evidence="ECO:0007829|PDB:2C1M"
FT   HELIX           32..35
FT                   /evidence="ECO:0007829|PDB:2C1M"
SQ   SEQUENCE   466 AA;  49485 MW;  8B9216CBB613661A CRC64;
     MAKRVAEKEL TDRNWDEEDE VEEMGTFSVA SEEVMKNRAV KKAKRRNVGF ESDSGGAFKG
     FKGLVVPSGG GGFSGFGGSG GKPLEGLTNG NSTDNATPFS NVKTAAEPKA AFGSFAVNGP
     TTLVDKKISS PKCNNSNQPP SSGPASSTAC PGNAYHKQLA GLNCSVRDWI VKHVNTNPLC
     DLTPIFKDYE RYLATIEKQL ENGGGSSSES QTDRATAGME PPSLFGSTKL QQESPFSFHG
     NKAEDTSEKV EFTAEKKSDA AQGATSASFS FGKKIESSAL GSLSSGSLTG FSFSAGSSSL
     FGKDAAQSKA ASSLFSAKAS ESPAGGGSSE CRDGEEEEND EPPKVVVTEV KEEDAFYSKK
     CKLFYKKDNE FKEKGVGTLH LKPTATQKTQ LLVRADTNLG NILLNVLIAP NMPCTRTGKN
     NVLIVCVPNP PLDEKQPTLP ATMLIRVKTS EDADELHKIL LEKKDA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024